These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37121468)

  • 21. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications.
    Chiuve SE; McCullough ML; Sacks FM; Rimm EB
    Circulation; 2006 Jul; 114(2):160-7. PubMed ID: 16818808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Under-use of appropriate blood pressure-lowering and lipid-lowering therapy in the Busselton baby boomer population.
    Yiu W; Knuiman M; Wallace H; Hung J
    Aust J Gen Pract; 2019 Dec; 48(12):883-889. PubMed ID: 31774993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe.
    Achelrod D; Gray A; Preiss D; Mihaylova B
    Eur J Prev Cardiol; 2017 Mar; 24(4):426-436. PubMed ID: 27799597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.
    Karlsson SA; Hero C; Svensson AM; Franzén S; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Eliasson B; Andersson Sundell K
    BMJ Open; 2018 Mar; 8(3):e020309. PubMed ID: 29602853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15).
    Mehta S; Wells S; Riddell T; Kerr A; Pylypchuk R; Marshall R; Ameratunga S; Chan WC; Thornley S; Crengle S; Harrison J; Drury P; Elley CR; Bell F; Jackson R
    J Prim Health Care; 2011 Jun; 3(2):93-101. PubMed ID: 21625656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial.
    Vagholkar S; Zwar N; Jayasinghe UW; Denney-Wilson E; Patel A; Campbell T; Harris MF
    Am Heart J; 2014 Jan; 167(1):28-35. PubMed ID: 24332139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prescribing of cardioprotective medications and the impact on survival for patients with peripheral artery disease that undergo intervention.
    Hart O; Xue N; Khashram M
    ANZ J Surg; 2023 Oct; 93(10):2376-2381. PubMed ID: 37370242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherosclerotic disease location and disparities in the control and treatment of cardiovascular risk factors in patients with Type 2 diabetes.
    Berthold HK; Bestehorn KP; Krone W; Gouni-Berthold I
    Diabet Med; 2010 Mar; 27(3):303-8. PubMed ID: 20536493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.
    Le Goff D; Aerts N; Odorico M; Guillou-Landreat M; Perraud G; Bastiaens H; Musinguzi G; Le Reste JY; Barais M
    Int J Behav Nutr Phys Act; 2023 Jul; 20(1):93. PubMed ID: 37507692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of orlistat initiation on cardiovascular treatment use: a 6-year population-based cohort study.
    Czernichow S; Knol MJ; Fezeu L; Grobbee DE
    Eur J Prev Cardiol; 2012 Jun; 19(3):484-9. PubMed ID: 21464100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases.
    Rees K; Al-Khudairy L; Takeda A; Stranges S
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013501. PubMed ID: 33629376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambient air pollution, healthy diet and vegetable intakes, and mortality: a prospective UK Biobank study.
    Wang M; Zhou T; Song Q; Ma H; Hu Y; Heianza Y; Qi L
    Int J Epidemiol; 2022 Aug; 51(4):1243-1253. PubMed ID: 35179602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and factors associated with lipid-lowering medications use for primary and secondary prevention of cardiovascular diseases among Malaysians: the REDISCOVER study.
    Baharudin N; Mohamed-Yassin MS; Daher AM; Ramli AS; Khan NMN; Abdul-Razak S
    BMC Public Health; 2022 Feb; 22(1):228. PubMed ID: 35120488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between changes in health behaviour and initiation of lipid-lowering and antihypertensive medications in individuals at high risk of ischaemic heart disease.
    Hempler NF; Krasnik A; Pisinger C; Jørgensen T
    BMC Public Health; 2012 Aug; 12():626. PubMed ID: 22873800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).
    Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D
    Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences.
    Chowdhury R; Khan H; Heydon E; Shroufi A; Fahimi S; Moore C; Stricker B; Mendis S; Hofman A; Mant J; Franco OH
    Eur Heart J; 2013 Oct; 34(38):2940-8. PubMed ID: 23907142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined antihypertensive and statin therapy for the prevention of cardiovascular events in patients with hypertension without complications: protocol for a systematic review and meta-analysis.
    Wang Y; Kuang ZM; Feng SJ; Jiang L; Chen QX; Ji XY; Cheng WL; Hu HJ
    BMJ Open; 2018 May; 8(5):e019719. PubMed ID: 29858408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.